Movement Alert|Teradyne Rises 3.75% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations as AI Chip Testing Demand Surges

Market Focus07-30 16:31

On July 30, Teradyne rose 3.75% in pre-market trading, trading at $331.392/share, with turnover of $1.2459 million, extending post-earnings momentum.

The company reported Q2 adjusted EPS of $2.47, far exceeding the consensus estimate of $2.09, representing a 333% year-over-year increase from $0.57. Revenue reached $1.33 billion, up 104% year-over-year, surpassing expectations of $1.22 billion. The semiconductor test segment contributed $1.122 billion, driven by robust AI chip testing demand. Net income surged to $374.5 million from $78.4 million a year earlier.

Q3 guidance was equally strong, with revenue projected at $1.2 billion to $1.3 billion, well above the Street estimate of $1.06 billion, and adjusted EPS guidance of $1.85 to $2.15, with the midpoint of $2.00 far exceeding analysts' $1.44 expectation. Cantor Fitzgerald raised its target price from $400 to $550, maintaining an overweight rating. Previously, UBS, JPMorgan, and Goldman Sachs had also lifted targets to the $450-$500 range, reflecting strong institutional confidence in AI-driven growth sustainability.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment